Novogen Ltd (NRT)-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Novogen Ltd (NRT)-Pharmaceuticals & Healthcare-Deals and Alliances Profile


  • Products Id :- GDPH62552D
  • |
  • Pages: 45
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Novogen Ltd (Novogen) is a clinical stage biotechnology company which focuses on the discovery and development of anti-cancer drugs. It develops its products based on two main drug technology platforms, anti-tropomyosins (ATM) and super-benzopyrans (SBP). ATM drugs that target the cancer cell cytoskeleton are being developed for the treatment of melanoma, prostate cancer and neuroblastoma. SBP drugs that target cancer stem cells are being developed for the treatment of ovarian cancer and glioblastoma. The company's major drug candidates include is Cantrixil (TRX-E-002-1); Trilexium (TRXE-009-1)and Anisina (ATM-3507). Novogen is headquartered in New South Wales, Australia.

Novogen Ltd (NRT)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Novogen Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Novogen Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

Novogen Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

Novogen Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

Novogen Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Novogen Ltd, Pharmaceuticals & Healthcare, Deal Details 12

Asset Purchase 12

Novogen Acquires Anti-Tropomyosins Drug Technology From Genscreen 12

Partnerships 13

Novogen Enters into Contract Research Agreement with Novotech 13

Novogen to Enter into Co-Development Agreement with Feinstein Institute for Medical Research for Brain Cancer 13

Novogen Enters into Agreement with Genea Biocells 14

Novogen Forms Joint Venture With Yale University 15

Novogen Enters Into Agreement With The Ingham Institute For Applied Medical Research 16

Licensing Agreements 17

Novogen Enters into Licensing Agreement with Genentech for GDC-0084 17

Equity Offering 18

Novogen Raises USD13 Million in Rights Offering of Shares 18

Novogen to Raise USD0.51 Million in Private Placement of Shares 19

Novogen Raises USD12 Million in Private Placement of Shares 20

Novogen to Raise Additional USD1.4 million in Private Placement of Shares 21

Novogen Completes Second Tranche Of Private Placement Of Shares For US$0.14 Million 22

Novogen Completes Rights Offering Of Shares For US$0.8 Million 23

Novogen Completes Private Placement Of Shares For US$2 Million 24

Marshall Edwards Completes Private Placement Of Common Stock For US$2 Million 25

Marshall Edwards Completes Private Placement Of Common Stock For US$2 Million 26

Debt Offering 27

Novogen Completes Third Tranche of Private Placement Of Private Placement Of Note For US$3.7 Million 27

Asset Transactions 28

TR Therapeutics Completes Acquisition Of Glucan Technology Assets From Novogen 28

Pharm-a-Care Labs Completes Acquisition Of Consumer Products Business From Novogen For US$10.8 Million 29

Marshall Edwards Completes Acquisition Of Intellectual Property Portfolio From Novogen 30

Acquisition 31

Novogen Acquires Glioblast for USD1.6 Million 31

Novogen Completes Acquisition Of Triaxial Pharma For US$2 Million 32

Novogen Ltd-Key Competitors 34

Key Employees 35

Locations And Subsidiaries 36

Head Office 36

Other Locations & Subsidiaries 36

Recent Developments 37

Corporate Communications 37

Mar 10, 2017: Novogen Announces Transformation to a Clinical Stage Organisation Leads to Changes in Management Structure 37

Mar 10, 2017: Novogen: Transformation To A Clinical Stage Organisation Leads To Changes In Management Structure 38

Aug 29, 2016: Novogen Appoints Key Management Personnel To Drive Transition To A Development-Focused Organisation 39

Feb 05, 2016: Novogen Announces Changes to the Board with New Chairman and Deputy Chairman Appointed 40

Product News 41

03/16/2016: Novogen Receives R&D Tax Incentive Cash Refund 41

Product Approvals 42

Aug 11, 2016: Novogen Submits Investigational New Drug (IND) Application to the US FDA For Cantrixil in Ovarian Cancer 42

Clinical Trials 43

Sep 12, 2016: US FDA Approves Investigational New Drug (IND) Application For Cantrixil (TRX-E-002-1) In Ovarian Cancer 43

May 02, 2016: Novogen Provides Update On Development Of Cantrixil 44

Appendix 45

Methodology 45

About GlobalData 45

Contact Us 45

Disclaimer 45

List of Figures

Novogen Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Novogen Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Novogen Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Novogen Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Novogen Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

Novogen Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 7

Novogen Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

Novogen Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

List of Tables

Novogen Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 1

Novogen Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

Novogen Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

Novogen Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

Novogen Ltd, Deals By Therapy Area, 2011 to YTD 2017 9

Novogen Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Novogen Acquires Anti-Tropomyosins Drug Technology From Genscreen 12

Novogen Enters into Contract Research Agreement with Novotech 13

Novogen to Enter into Co-Development Agreement with Feinstein Institute for Medical Research for Brain Cancer 13

Novogen Enters into Agreement with Genea Biocells 14

Novogen Forms Joint Venture With Yale University 15

Novogen Enters Into Agreement With The Ingham Institute For Applied Medical Research 16

Novogen Enters into Licensing Agreement with Genentech for GDC-0084 17

Novogen Raises USD13 Million in Rights Offering of Shares 18

Novogen to Raise USD0.51 Million in Private Placement of Shares 19

Novogen Raises USD12 Million in Private Placement of Shares 20

Novogen to Raise Additional USD1.4 million in Private Placement of Shares 21

Novogen Completes Second Tranche Of Private Placement Of Shares For US$0.14 Million 22

Novogen Completes Rights Offering Of Shares For US$0.8 Million 23

Novogen Completes Private Placement Of Shares For US$2 Million 24

Marshall Edwards Completes Private Placement Of Common Stock For US$2 Million 25

Marshall Edwards Completes Private Placement Of Common Stock For US$2 Million 26

Novogen Completes Third Tranche of Private Placement Of Private Placement Of Note For US$3.7 Million 27

TR Therapeutics Completes Acquisition Of Glucan Technology Assets From Novogen 28

Pharm-a-Care Labs Completes Acquisition Of Consumer Products Business From Novogen For US$10.8 Million 29

Marshall Edwards Completes Acquisition Of Intellectual Property Portfolio From Novogen 30

Novogen Acquires Glioblast for USD1.6 Million 31

Novogen Completes Acquisition Of Triaxial Pharma For US$2 Million 32

Novogen Ltd, Key Competitors 34

Novogen Ltd, Key Employees 35

Novogen Ltd, Subsidiaries 36

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Novogen Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license

Single User License
USD 250 INR 16040
Site License
USD 500 INR 32080
Corporate User License
USD 750 INR 48120

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com